Borg Pharmaceutical Industries
알렉산드리아의 의약품 및 보충제 제조
Borg Pharmaceutical Industries는 의약품, 화장품, 건강보조식품을 제조합니다. 이집트 의료 채널과 일부 국제 시장을 위한 제품을 포장하고 배포합니다.
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Alexandria, Egypt
- Founded
- 2001
- Website
- https://www.borg-pharma.com
- Categories
- 스킨케어 및 화장품, 보충제 및 웰니스, 의료 및 건강 관리 용품
- Markets
- 이집트
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-06 Mail server of the company domain
- domain-registered (green), checked 2026-08-06 Domain registry record
- sanctions-clear (green), checked 2026-08-06 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- debarment-clear (green), checked 2026-08-06 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
Import rules for these goods
- Cosmetic products must be notified in the EU Cosmetic Products Notification Portal (CPNP) before being placed on the EU market. European Commission (CPNP)
- For the US market, MoCRA requires cosmetic facility registration and product listing with the FDA. US FDA (MoCRA)
- Food supplements sold in the EU follow Directive 2002/46/EC: most member states require a notification to the national authority before the first sale. European Commission (supplements)
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)